🧪
hypothesis

Metabolic Checkpoint Reprogramming via TREM2-mTOR Axis

Hypothesis

Metabolic Checkpoint Reprogramming via TREM2-mTOR Axis

Restore oxidative metabolism in APOE4 microglia through CNS-penetrant mTOR modulators that reactivate oxidative phosphorylation while maintaining inflammatory responsiveness.
🧬 MTOR🩺 neurodegeneration🎯 Composite 46%💱 $0.52▲5.7%active
EvidencePending (0%)📖 5 cit🗣 1 debates 5 support 3 oppose
✓ All Quality Gates Passed
Mechanistic 0.50 (15%) Evidence 0.50 (15%) Novelty 0.50 (12%) Feasibility 0.50 (12%) Impact 0.00 (12%) Druggability 0.50 (10%) Safety 0.50 (8%) Competition 0.50 (6%) Data Avail. 0.50 (5%) Reproducible 0.50 (5%) KG Connect 0.58 (8%) 0.455 composite
☰ Compare⚔️ Duel⚛️ Collide
📄 Export LaTeX
arXiv PreprintNeurIPSNature MethodsPLOS ONE
📖 Export BibTeXinteract with this hypothesis
Composite46%

🧪 Overview

Restore oxidative metabolism in APOE4 microglia through CNS-penetrant mTOR modulators that reactivate oxidative phosphorylation while maintaining inflammatory responsiveness

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["APOE4 Microglial Dysfunction<br/>TREM2 mTORC1 Axis Dysregulated"]
    B["mTORC1 Hyperactivation<br/>TREM2-Akt-mTOR Pathway"]
    C["Oxidative Phosphorylation Suppressed<br/>Glycolytic Shift in Microglia"]
    D["Inflammatory Priming<br/>Pro-Inflammatory Gene Program"]
    E["CNS-Penetrant mTOR Modulator<br/>Rapamycin Analog Torin-2"]
    F["mTORC1 Partial Inhibition<br/>Metabolic Flexibility Restored"]
    G["OXPHOS Re-Engaged<br/>Anti-Inflammatory Phenotype"]
    H["Inflammatory Responsiveness Preserved<br/>Not Full Immunosuppression"]
    I["APOE4 Microglial Rescue<br/>AD Neuroinflammation Reduced"]
    A --> B
    B --> C
    C --> D
    E --> F
    F --> G
    F --> H
    G --> I
    H --> I
    style B fill:#7b1fa2,stroke:#ce93d8,color:#ce93d8
    style I fill:#1b5e20,stroke:#a5d6a7,color:#a5d6a7

⚖️ Evidence

⚖️ Evidence Matrix5 supports3 contradicts
Supports
TREM2 drives microglia response to amyloid-β via SYK-dependent and -independent pathways.
Cell2022PMID:36306735medium
Supports
TREM2, microglia, and Alzheimer's disease.
Mech Ageing Dev2021PMID:33516818medium
Supports
Microglia and TREM2.
Neuropharmacology2024PMID:38821351medium
Supports
A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease.
Cell2017PMID:28602351medium
Supports
Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer's disease model.
J Exp Med2020PMID:32579671medium
Contradicts
mTOR at the nexus of nutrition, growth, ageing and disease.
Nat Rev Mol Cell Biol2020PMID:31937935medium
Contradicts
mTOR signaling in growth control and disease.
Cell2012PMID:22500797medium
Contradicts
Insulin Resistance and Diabetes Mellitus in Alzheimer's Disease.
Cells2021PMID:34069890medium
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — MTOR

No curated PDB or AlphaFold mapping for MTOR yet. Search RCSB →

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for MTOR →

No DepMap CRISPR Chronos data found for MTOR.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
High
0.0527
Events (7d)
0
Price History
▲5.7%

💾 Resource Usage

LLM Tokens
12,984
$0.0779
Total Cost
$0.0779
View on SciDEX ↗